3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
72
Neoplasms
7
Neoplasm Metastasis
7
Breast Diseases
5
Neoplasms by Site
3
Carcinoma, Intraductal, Noninfiltrating
3
Breast Neoplasms, Male
3
Ovarian Neoplasms
2
Endometrial Neoplasms
2
Breast Neoplasm Female
2
Advanced Breast Cancer
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Diseases
1
Sexual Dysfunctions, Psychological
1
Low Grade Serous Ovarian Cancer
1
Locoregional Recurrence
1
Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
HER2-positive Breast Cancer
1
HER2 Negative Breast Cancer
1
Granulosa Cell Ovarian Cancer
1
Fallopian Tube Neoplasms
1
Endometrial Stromal Tumors
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Lobular
1
Carcinoma, Ductal, Breast
1
Breast Carcinoma In Situ
1
Interventions
exemestane
1
Therapeutics
1
Letrozole
1
Aromatase Inhibitors
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Endometrial Stromal Tumors
×
Anastrozole
×
1 year
×
Clear all
NCT03624244
2026-02-17
BFR-ESS
Centre Leon Berard
Phase 2
Recruiting
40 enrolled